CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A'sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2]

By | 2016-02-07T23:23:17+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [Hainan Helpson Medical & Biotechnology Long-term Laborntract Employer:Hainan Helpson Medical & Biotechnology (hereunderlled Party A ormpany) Zhilin Li Legal Representative/ authorisedent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A'sdress: 570216 Postde: Zhilin Li (hereunderlled Party B)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 -------------------------------- President and Chief Executive Officer cphi10qex321093010.htm 5 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:November 10, 2010 --------------------- (principal financial officer and principal accounting officer) cphi10qex322093010.htm 6 EX-32.2]

By | 2016-02-07T23:23:50+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 81,341,504 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739%]

By | 2016-04-02T19:03:05+00:00 November 10th, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: Item 1: Reporting Person – FMR LLC Item

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 81,341,504 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 81,967,904 Item 8: 0 Item 9: 81,967,904 Item 11: 14.739%]

By | 2016-04-02T19:04:01+00:00 November 10th, 2010|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)

[Louis Taubman (Admitted NY) lou@lhttlaw.com Email November 5, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc: Dr. Jiang, Tianyin Pharmaceutical Co., Inc. CEO]

By | 2016-03-27T22:00:16+00:00 November 5th, 2010|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] CORRESP: Louis Taubman (Admitted NY) lou@lhttlaw.com Email November 5,

[Louis Taubman (Admitted NY) lou@lhttlaw.com Email November 5, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc: Dr. Jiang, Tianyin Pharmaceutical Co., Inc. CEO]

By | 2016-03-27T22:01:14+00:00 November 5th, 2010|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): October 27, 2010 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20- 8747899 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xianyang City, Shaanxi Province People’s Republic of China 86-029-33686638 (Issuer Telephone Number) N/A (Former name or former address, if]

By | 2016-03-03T13:49:30+00:00 October 29th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: FORM 8-K CURRENT REPORT Date of report (Date

[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): October 27, 2010 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20- 8747899 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xianyang City, Shaanxi Province People’s Republic of China 86-029-33686638 (Issuer Telephone Number) N/A (Former name or former address, if]

By | 2016-03-03T13:50:48+00:00 October 29th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): October 27, 2010 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20- 8747899 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xianyang City, Shaanxi Province Peoples Republic of China 86-029-33686638 (Issuer Telephone Number)]

By | 2016-02-07T16:43:11+00:00 October 29th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: FORM 8-K CURRENT REPORTte of report (Date of

[FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): October 27, 2010 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20- 8747899 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xianyang City, Shaanxi Province Peoples Republic of China 86-029-33686638 (Issuer Telephone Number)]

By | 2016-02-07T16:44:08+00:00 October 29th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar